little confused wf, Taryn, if not a personal question, how long have you worked for Admedus Investor Relations?
Few of your previous posts have asked for info in relation to Admedus, (?) that aside thank you for your time to have posted.
One question though, presume it may be confidential (if applicable) ; can any of the scenarios in listing rule 2.1 be 100% ruled out?, IF so (ruled out) then acknowledged by the company?
Thank you in advance, cheers.
Ann: Suspension from Official Quotation - Annual Listing Fee, page-46
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.40 |
Change
0.310(2.05%) |
Mkt cap ! $325.5M | |||
| Open | High | Low | Value | Volume |
| $15.57 | $15.84 | $15.15 | $452.1K | 29.37K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1000 | $15.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.40 | 2886 | 1 |
View Market Depth
| Last trade - 16.10pm 21/08/2024 (20 minute delay) ? |
| AVR (ASX) Chart |